Performance analysis of Benitec Biopharma (BNTC)
Annual Return
Over the past 3 years, BNTC has had an average annual return of +48.65%, outperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, BNTC has had an average annual return of -28.93%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, BNTC has had an average annual return of -30.75%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Aug 18, 2015, BNTC has had an average annual return of -37.47%, underperforming the benchmark SPY, which returned +14.22% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.61% | +6.45% | +287.50% | +14.29% | -93.61% | -12.75% | -60.84% | -65.98% | -49.27% | +93.44% | -61.93% | -49.56% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.09% | -10.00% | -3.70% | +13.46% | -3.39% | +15.79% | -10.61% | -10.61% | |||||
| 2025 | -8.06% | +10.53% | +1.59% | +4.69% | +13.43% | -23.68% | -6.90% | +20.37% | +6.15% | +17.39% | -20.99% | +3.13% | +6.45% |
| 2024 | -12.50% | +71.43% | +8.33% | +61.54% | -9.52% | -10.53% | +23.53% | +9.52% | -2.17% | +15.56% | -3.85% | +24% | +287.50% |
| 2023 | +35.71% | +31.58% | -28.00% | -5.56% | +17.65% | -0% | -25.00% | +0% | +0% | +20% | -11.11% | +0% | +14.29% |
| 2022 | -6.39% | -5.37% | +1.03% | -35.71% | -30.16% | +10.23% | -22.68% | -17.33% | -50.00% | -51.61% | +13.33% | -17.65% | -93.61% |
| 2021 | +33.86% | -21.43% | +64.02% | -17.32% | +10.06% | -9.64% | -17.70% | +13.31% | -9.94% | +2.68% | -16.61% | -14.45% | -12.75% |
| 2020 | -10.45% | +13.41% | -24.12% | +54.25% | -19.82% | +8.35% | -9.67% | -2.51% | -9.78% | -57.22% | +10.22% | +1.21% | -60.84% |
| 2019 | -7.06% | +29.87% | +8.27% | +2.03% | -19.98% | -53.18% | +13.50% | -15.36% | -1.22% | -6.83% | -18.63% | -5.32% | -65.98% |
| 2018 | +22.29% | -18.52% | +7.94% | -17.72% | +1.16% | -24.81% | +48.24% | -3.72% | -16.56% | +0.03% | -13.10% | -27.20% | -49.27% |
| 2017 | +12.40% | +56.39% | +2.61% | -7.25% | -12.89% | -17.05% | +22.19% | -9.31% | +5.87% | +31.33% | +1.76% | +2.06% | +93.44% |
Drawdown analysis of Benitec Biopharma (BNTC)
The maximum drawdown for the BNTC was -99.91%, occurring on Aug 7, 2023. This drawdown has not yet recovered.
The current BNTC drawdown is -99.44%.
Since Aug 18, 2015 BNTC has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.91% | Aug 20, 2015 | 2003 | Aug 7, 2023 | Ongoing | Ongoing | Ongoing |